Skip to content

Comparison between effect of low-power laser therapy versus local methylprednisolone injection on plantar fascitis in patients refer to Rheumatology clinic

Comparison between effect of low-power laser therapy versus local methylprednisolone injection on plantar fascitis in patients refer to rheumatology clinic

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201110247877N1
Enrollment
40
Registered
2011-12-14
Start date
2011-07-28
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar fasciitis. Plantar fasciitis

Interventions

Intervention 1: Group 1: Methylprednisolone injection once a week for 3 weeks. Intervention 2: Group2:Low-power laser in a ten session in every other day.
Treatment - Drugs
Group 1: Methylprednisolone injection once a week for 3 weeks
Group2:Low-power laser in a ten session in every other day

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
22 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients have 22-65 years with unilateral plantar fascitis and duration of pain more than 6 week , Exclusion criteria:patients with bilateral Plantar fascitis; there was history of recent trauma or foot surgery; enrolled during recent 3-6 months therapeutic protocol; there was a previous diagnosis of rheumatoid arthritis; seronegative spondyloarthropathy; cacaneal stress fracture, osteomyelitis; plantar fascia neoplasm and plantar aponeurosis rupture

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The heel pain. Timepoint: After a night of rest and 6 weeks after treatment - after an active day and 6 weeks after treatment. Method of measurement: Visual analog scale.;Tenderness on the junction of plantar fascia. Timepoint: One and six weeks after treatment. Method of measurement: Visual analog scale.

Secondary

MeasureTime frame
Infection at injection site. Timepoint: One and six weeks after injection. Method of measurement: Physical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Batol Zamani

kashan Univercity of Medical Sciences

batol_zamani2007@yahoo.com+98 36 1555 4296

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026